Plasma biomarkers for mild cognitive impairment and Alzheimer's disease
Purpose of review: With the move toward development of disease modifying treatments,
there is a need for more specific diagnosis of early Alzheimer's disease (AD) and mild …
there is a need for more specific diagnosis of early Alzheimer's disease (AD) and mild …
Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease
M Bettinetti‐Luque, L Trujillo‐Estrada… - British Journal of …, 2024 - Wiley Online Library
Adipose tissue has recently been recognized as an important endocrine organ that plays a
crucial role in energy metabolism and in the immune response in many metabolic tissues …
crucial role in energy metabolism and in the immune response in many metabolic tissues …
Blood–brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment
Background Functional loss of blood–brain barrier (BBB) is suggested to be pivotal to
pathogenesis and pathology of vascular-based neurodegenerative disorders such as …
pathogenesis and pathology of vascular-based neurodegenerative disorders such as …
Plasma proteins predict conversion to dementia from prodromal disease
A Hye, J Riddoch‐Contreras, AL Baird… - Alzheimer's & …, 2014 - Wiley Online Library
Background The study aimed to validate previously discovered plasma biomarkers
associated with AD, using a design based on imaging measures as surrogate for disease …
associated with AD, using a design based on imaging measures as surrogate for disease …
Klotho overexpression improves amyloid‐β clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease
Y Zhao, CY Zeng, XH Li, TT Yang, X Kuang, JR Du - Aging Cell, 2020 - Wiley Online Library
Alzheimer's disease (AD) is the most prevalent type of dementia, characterized by the
presence of amyloid‐β (Aβ) plaques. We previously reported that Klotho lowered Aβ levels …
presence of amyloid‐β (Aβ) plaques. We previously reported that Klotho lowered Aβ levels …
Blood-brain barrier dysfunction precedes cognitive decline and neurodegeneration in diabetic insulin resistant mouse model: an implication for causal link
Diabetic insulin resistance and pro-diabetic diet are reported to increase dementia risk
through unknown mechanisms. Emerging evidence suggests that the integrity of blood-brain …
through unknown mechanisms. Emerging evidence suggests that the integrity of blood-brain …
Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals
Objectives Apolipoproteins have recently been implicated in the etiology of Alzheimer's
disease (AD). In particular, Apolipoprotein J (ApoJ or clusterin) has been proposed as a …
disease (AD). In particular, Apolipoprotein J (ApoJ or clusterin) has been proposed as a …
Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice
NF Fitz, A Cronican, T Pham, A Fogg… - Journal of …, 2010 - Soc Neuroscience
High-fat diet and certain dietary patterns are associated with higher incidence of sporadic
Alzheimer's disease (AD) and cognitive decline. However, no specific therapy has been …
Alzheimer's disease (AD) and cognitive decline. However, no specific therapy has been …
Long-term exposition to a high fat diet favors the appearance of β-amyloid depositions in the brain of C57BL/6J mice. A potential model of sporadic Alzheimer's …
Aims The sporadic and late-onset form of Alzheimer's disease (AD) constitutes the most
common form of dementia. This non-familiar form could be a consequence of metabolic …
common form of dementia. This non-familiar form could be a consequence of metabolic …
Synthesis of human amyloid restricted to liver results in an Alzheimer disease–like neurodegenerative phenotype
Several lines of study suggest that peripheral metabolism of amyloid beta (Aß) is associated
with risk for Alzheimer disease (AD). In blood, greater than 90% of Aß is complexed as an …
with risk for Alzheimer disease (AD). In blood, greater than 90% of Aß is complexed as an …